Currently predicting for Thu, 20 Jun 2024

Trading levels for GRFS

Fibonacci Support & Resistance Levels

Level Price
R3 7.23 3.04%
R2 7.17 2.17%
R1 7.13 1.63%
Price 7.02
S1 7.01 -0.111%
S2 6.97 -0.649%
S3 6.91 -1.52%

Accumulated Volume Support & Resistance Levels

Level Price
R3 7.47 6.41%
R2 7.29 3.85%
R1 7.11 1.28%
Price 7.02
S1 6.78 -3.42%
S2 6.48 -7.69%
S3 6.22 -11.40%

GRFS Predictions History

3 months ago
JS predicted that GRFS for Mar. 13th is going $6.11 (-3.63%)

3 months ago
PredictionBot.Kathy predicted that GRFS for Mar. 13th is going $6.04 (-4.75%)

3 months ago
PredictionBot.Warren predicted that GRFS for Mar. 13th is going $6.13 (-3.27%)

3 months ago
monisha.abichandani.409965 predicted that GRFS for Mar. 13th is going

Rank:

2 years ago
RamboRex3000 predicted that GRFS for 2021-08-23 is going $15.23 (2.28%)

2 years ago
JS predicted that GRFS for 2021-08-23 is going $15.12 (1.54%)

2 years ago
Trinkz predicted that GRFS for 2021-08-23 is going $17.90 (19.25%)

Rank:

5 years ago
NameNotImportant predicted that GRFS for 2019-05-06 is going $19.43 (0.88%)

5 years ago
NameNotImportant predicted that GRFS for 2019-05-02 is going $20.30 (6.79%)

5 years ago
NameNotImportant predicted that GRFS for 2019-04-22 is going $18.75 (0.48%)

Click to get the best stock tips daily for free!

About Grifols

Grifols Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunogl... GRFS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT